MSI2 and hepatocellular carcinoma: To further investigate the effect of MSI2 in Jolkinolide B-induced HCC progression, Huh-7 and SK-Hep-1 cells were treated with DMSO, Jolkinolide B, or Jolkinolide B and MSI2 plasmids.